Tag: PZOO

Blue Horseshoe Stocks: PZOO Hits New Highs & More

Pazoo, Inc. PZOO

PZOO continued its established pattern of offering up sizable intraday swings, and went on to set a new high during yesterday’s session. It did hold support at a penny as we hoped it would, and traded up as high as .0125, for a 25% intraday move.

Our observed low on this play came a couple of weeks ago at .0049. Yesterday’s new high brought our total observed range on PZOO to 155%

The company also alerted us yesterday via a midday PR that its medical marijuana testing partner would be joining the newly-formed Nevada Cannabis Laboratory Association (NVCLA), which is the first such coalition to be formed in the state.

Voltari Corp. VLTC

VLTC’s epic run over the past three weeks, which we were just commenting on in yesterday’s pre-market report, received another boost with a noteworthy
performance that led to new annual highs once again.

The daily range on VLTC was 11.11 to 19.20, for a big intraday move of 73% Measured from the low of 2.14 we observed just three weeks ago to the day, that’s an enormous 797% swing. We’d call it incredible, but gains approaching (and often exceeding) the 1000% neighborhood are fairly commonplace for us, as anyone who has followed our reports for awhile can attest.

Our position with regard to how we’ll be approaching VLTC in coming sessions remains the same: Take advantage of any further increases with quick-trigger intraday trades, while keeping a sharp lookout for a sustained pullback.

Carl Icahn’s name and reputation have essentially been leading the way as the stock pushed to that impressive new 52-week high. When immaterial excitement propels a stock so high, so fast, we can be sure that a sell-off is somewhere on the horizon. Signs of that potential outcome were visible toward the end of the session as VLTC settled back to the $16-range at the close.

We’ll watch today for the possibility of a dip-and-rip scenario as VLTC is gapping up in early trading. Any consolidation is sure to lead to a potential bounce-play at some point, and as always, we’ll be ready to take advantage of those swings when they occur.

OSL Holdings, Inc. OSLH

Speaking of potential bounce-plays (and thousand-percent gainers, for that matter), we want to quickly jump back to OSLH, stock we currently have on bottom-watch. If you’ve been following along with our reports this month, you were with us as it exploded on a 1294% rip from .0021 (04/02) to .0274 (04/15).

OSLH has been peeling back off of those impressive highs over the past couple of sessions, and we’re going to want to keep a close eye for when it establishes a solid level of support, preferably at or above the penny mark. Opportunities should be available for quick gains on the subsequent rebound.

Yahoo, Inc. YHOO – Options Ideas

Despite YHOO falling short on earnings in its report out after yesterday’s close, we will be looking for any potential dip-and-rip scenarios, provided it can hold support at the 50DMA of 44.12 on any pullbacks.

We will be watching the $44-45 Calls and Puts, choosing when it becomes apparent which way the trend will carry. We can then jump in the money with our strike price and could be looking at significant gain opportunities.

If YHOO doesn’t hold that 50DMA as support then we would look for a protracted pullback and some added downside pressure, and go to the Put-side. If it can dip-and-rip, the Calls will see the action.

Extended Watchlist:
PKT, GBSN, ONVO, ANGI, CTIC, VGGL

Blue Horseshoe Stocks: VLTC Recap & More

Voltari Corp. VLTC

A unique opportunity presented itself when billionaire activist investor Carl Icahn disclosed his increased position in VLTC (52% ownership) on April 1st. We tagged the stock in our premarket report that morning as it was gapping up, and have become more and more pleased with that decision as time goes on.

After witnessing a low of 2.18 the following day, it has been mostly northward movement as the stock has slowly but surely made its way to impressive new highs. We’ve been tracking it all along the way, with routine followup mentions on the 8th, 10th, 16th, and again in yesterday’s report.

During yesterday’s session VLTC made a nice move from a low of 8.75 to a new 52-week high of 10.41 at the close. It marked a healthy intraday run of 19%, and represents an overall increase of 377% from our observed low on April 2nd.

Anyone trading in this play has certainly thought of taking profits by this point, and reasonably so. That being said, with a high-profile investor like Icahn involved, we’ll have to be sure we don’t let VLTC slip off of our radars as we go forward.

When we finally do see a consolidation off of this historic run, we’ll immediately transition into bottom-watch mode and lay in wait for a subsequent rebound.

Pazoo, Inc. PZOO

We also want to give a quick update on PZOO, which as our readers are aware, we’ve been tracking pretty heavily in recent weeks. Like VLTC, it was also April 1st that we re-introduced this one into the mix. We’ve witnessed many intraday swings since then, that have offered multiple opportunities for successful trades.

Yesterday, the stock made its way from a daily low .0093 and spiked 18% to a new high of .011. That means that from the low of .0049 we observed on April 6th, PZOO had increased by a total of 124% It also closed at .0105; we’d like to see the stock work toward building a base of support at that key penny-level, however on any potential pullbacks we’ll want to see it hold support at or above the channel between the current 50DMA of .0074 and .008.

As we mentioned yesterday, we’re still rather “high” on marijuana-related stocks and PZOO remains one of our favorite ones, in its unique niche of medical cannabis testing/analysis.

Extended Watchlist:
LRCX, MYL, BIOC, BCLI, IBIO, LRE, TWDL, WSTI

Blue Horseshoe Stocks: PMCB Update & More

PharmaCyte Biotech, Inc. PMCB

When we released a special report on PMCB back on Tuesday of last week, we commented on the promising nature of trials the company currently has underway relating to various treatments based on its Cell-in-a-Box® technology.

At the end of last week, PharmaCyte announced some promising research specifically pertaining to its diabetes treatment, with the claim that it can actually reverse Type-1 Diabetes in mice.The full paper can be found at http://www.nature.com/articles/mtm201511. Human trials are the next step to take, and needless to say, should the treatment prove effective using PMCB’s encapsulation technology (that we described in our initial report,) acquisition by a large pharmaceutical company could become a very real possibility.

That also seems to be the thinking on the Street, as PMCB has made some impressive strides on the chart over the past several sessions. From the low of .12 that we observed in this play on 04/08, it has made its way up as high as .22; a respectable 83% overall increase. That impressive high came during yesterday’s session in conjunction with a breach of the current 200DMA of .19.

PMCB will be one that we want to keep on continuous watch due to its potentially industry-disruptive diabetes treatment.

Pazoo, Inc. PZOO

PZOO has been a flipper’s dream since we re-initiated coverage on it just a couple of weeks ago. Yesterday’s low registered as .008 before the stock bounced back to .0097, a 21% intraday swing.

It was the same story on Wednesday; we saw PZOO dip to a low of .0074 before returning as high as .0103 (+39%) We’ve continually stated that we’d like to see the stock trading at or above the .008 range which, for the most part, it has continued to do.

CEO David Cunic appeared in an audio interview yesterday, and this morning we’re seeing another PR directing our attention to an 8-K filing which outlines a recent agreement, among other things, so our readers might want to check out those links.

In the meantime, we’ll be on the lookout for upcoming intraday gain opportunities from PZOO, such as those that it has delivered numerous time over the past several sessions.

Identiv, Inc. INVE

We also want to make a quick mention of INVE, which made a solid 14% move yesterday as it traded in a range from 11.12-12.67. It came on over ten times the 3-month average volume, so we’ll be observing this one as the week draws to a close, and possibly into next week.

Extended Watchlist:
RXII, ONCY, ZBB, UNXL

Blue Horseshoe Stocks: Late Breaking News – PZOO

Pazoo, Inc. PZOO

Yesterday, PZOO continued its trend of producing healthy daily swings, While PZOO did dip briefly below the 50DMA early on, it gave us a chance at a respectable intraday gain, as it has already done several times in the past couple of weeks. The daily range carried the stock from a low of .0074 back up to the penny mark; a 35% move that came on greater than average volume.

We were recently updated on the status of Pazoo partner, MA & Associates, whose cannabis testing facilities still await the first shipments of product for testing. The State of Nevada has delayed the release of regulatory guidelines for growers pertaining to standardized levels of pesticides, pushing the expected date of first delivery to sometime in June. It does give newly appointed marketing and sales executive Michael Tulimero added time to position the company to secure an even larger presence with growers, who are undoubtedly anticipating the regulatory green light from the State as eagerly as anyone. >> READ PR

We want to take note of the significant PR that just hit the wires at 9:45am:

WHIPPANY, N.J., April 15, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC:PZOO), is pleased to announce that as of yesterday, the company has completely repaid the total of its obligations on its Convertible Promissory Notes to LG Capital Funding LLC and Macallan Partners LLC. In addition, Pazoo has given notice of its intention to fully pay off the Convertible Promissory Notes held by Union Capital LLC by the end of next week and Eastmore Capital LLC within the next two weeks. The total of the obligations, repaid and planned for the next two weeks, is approximately $400,000.

Pazoo as a company felt it extremely important to eliminate any conversions of these notes into free trading shares of the company’s common stock. With the tremendous strides recently attained through our 100% subsidiary, Harris Lee, LLC and 40% owned MA & Associates, LLC, Pazoo is currently working towards more traditional financing vehicles. This will also tremendously benefit the company as it will free up tens of millions of reserve shares for the company’s use. >> VIEW FULL PR

Extended Watchlist:
ANGI, CLSN, FOMX, MCP, OSLH, PBR

Blue Horseshoe Stocks: PBR & PZOO Updates

Petroleo Brasiliero, S.A. (Petrobras) PBR

Our repeated success with PBR has become so consistent that it borders on the comical. Even after providing us with cumulative percentage gains numbering in the thousands over the past couple of weeks, as we were mentioning in yesterday morning’s report, the stock still won’t quit.

Though our history of tracking PBR stretches back for well over a year now, we recently resumed keeping close watch over it starting on March 26th. The following day, as you’ll see on the chart snapshot below, it found support at 5.60, and from there it has quickly made quite a significant move. Yesterday’s high of 8.30 represents a 48% swing over a span of just over two weeks.

Ordinarily, we’d make a few annotations to highlight the finer points of a chart, but the major move and bullish characteristics are pretty obvious at a single glance. The stock has achieved higher highs and higher lows for 10 out of the last 11 sessions!

With the magnitude of the rebound we’re seeing from PBR, this play is going to occupy a large majority of our focus as we head into the middle of the week. As long as the stock continues to show strength, we’ll be looking to leverage the move to our advantage with Weekly In-the-money Calls.

We’re also going to be very interested to follow all the price action leading up to and directly following PBR’s earnings call, which as we learned very early this morning, is coming up on April 22nd.

Pazoo, Inc. PZOO

We also wanted to quickly touch upon PZOO once again this morning to highlight the news update provided by the company yesterday, specifically pertaining to its subsidiary MA & Associates, which is currently in the process of establishing its medical marijuana testing business in Nevada.

The PR alluded to the creation of MA & Associates Marketing and Sales Division, and the appointment of industry-veteran Michael A. Tulimero to head it up. Pazoo describes him as “a highly regarded, experienced sales executive in the Cannabis industry,” mentioning his role in representing his company at the Cannabis Cup conferences in L.A. and Amsterdam, which are sponsored by world-renowned High Times magazine.

From a chart standpoint, yesterday’s session marked the sixth in a row that it has registered a higher low. We’ll look for that trend to continue, however, on any pullbacks we’ll want to see PZOO hold support at or above its 50-day moving average of .008.

Get Our FREE Daily Reports!

SUBSCRIBE